0:000:00
<p>Dr. John Sweetenham shares highlights from Day 4 of the 2025 ASCO Annual Meeting, including new research on maintenance therapy in small cell lung cancer and a virtual reality psychosocial intervention for patients undergoing hematopoietic stem cell transplantation.</p> <h2>Transcript</h2> <p class="MsoNormal"><span style= "font-size: 12.0pt; font-family: 'Calibri',sans-serif;">Hello, I'm Dr. John Sweetenham, the host of the <em>ASCO Daily News</em> Podcast, with my takeaways on selected abstracts from Day 4 of the 2025 ASCO Annual Meeting. My disclosures are available in the transcript of this episode.</span></p> <p class="MsoNormal"><span style= "font-size: 12.0pt; font-family: 'Calibri',sans-serif;">Today's selection features reports of 3 randomized trials in very different clinical settings: maintenance therapy in extensive small cell lung cancer (SCLC), upfront surgery in advanced ovarian cancer, and a supportive care intervention for patients undergoing hematopoietic stem cell...